Sun Pharmaceutical Industries Ltd. closed 10.67% short of its 52-week high of 1,960.20 rupees, which the company achieved on September 30th.

Sun Pharmaceutical Industries Ltd. closed 13.65% short of its 52-week high of 1,960.20 rupees, which the company reached on September 30th.

Aurobindo Pharma and Gland Pharma have fallen 6-10 per cent each in the past one week and 20-23 per cent in 2025 so far. Glenmark Pharma is down 10 per cent for the week month period and 14.45 per ...

Pharma Stocks; The Indian pharma market experienced a robust growth of 9.3% year-on-year in March 2025, with key players like ...

Mohegan Sun and A.T.Y Hospitality celebrated the grand opening of Sift Bake Shop and A.T.Y Bar & Bonbons, presented by Grey ...

Sun Life, in partnership with global sport for social change foundation Beyond Sport, has announced the extension of its "Hoops + Health" philanthropy program for the second year, with the goal of ...

The Nifty Pharma index closed at a gain of 2.25 percent by the end of the trading session today. IPCA Labs, Sun Pharma and Lupin emerging jumped up to 5 percent at intraday, and closed in a ...

Regardless of what level of buy-in exists within a company, an R&D organisation, or a lab, there is shared acknowledgement that AI is forever changing pharmaceutical research. And scientists need ...

If sold after 1 year from purchase date, long term capital gain tax will be applicable. Current tax rate is 12.5%, if your total long term capital gain exceeds 1.25 lakh. Any cess/surcharge is not ...

What is the Sun Pharmaceutical Industries Ltd share price today? The Sun Pharmaceutical Industries Ltd shares price on NATIONAL STOCK EXCHANGE (NSE) is ₹1734.7 today. What is the Market Cap of ...

Ajanta Pharma, Granules India, and Sun Pharmaceutical also traded with losses, ranging between 2% and 4%. Uncertainty surrounding the scale of US tariffs, the possibility of retaliatory measures ...

The Massachusetts-based Lyndra Therapeutics Inc “is ceasing operations from March 26th, due to insufficient funding to continue their business activities,” said Sun Pharmaceutical Industries ...